Patents by Inventor G. Andrews

G. Andrews has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus for capturing an image
    Publication number: 20030198365
    Abstract: A method and system for providing owners, potential buyers and other users of autographed items such as sports and other entertainment memorabilia visual evidence for verifying the authenticity of the autograph are described. A method of the present invention involves capturing an image of the signature as it is being placed on the item. The image so captured is then stored on a computer readable medium. In addition to the item itself, the owner of the item may be provided with a computer readable medium containing computer readable instructions for accessing the image and other information about the item, the signing process, the autographer, etc. The image may be captured by a camera mounted on a pen or other writing instrument.
    Type: Application
    Filed: May 21, 2003
    Publication date: October 23, 2003
    Applicant: THE UPPER DECK COMPANY, LLC.
    Inventors: Richard P. McWilliam, G. Lynn Hagen, Robert G. Andrews, Matthew Hoerr, Adam Christianson, Brenton Demko, William B. Abrahams, Richard Sutherland
  • Unique levothyroxine aqueous materials
    Publication number: 20030199586
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions and methods
    Publication number: 20030199585
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique Cmax properties
    Publication number: 20030199587
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triidothyronine plasma AUC properties
    Publication number: 20030198672
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 23, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Cmax properties
    Publication number: 20030194437
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 16, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Methods of administering levothyroxine pharmaceutical compositions
    Publication number: 20030194422
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 16, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030195254
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 16, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
    Publication number: 20030195253
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form, wherein the levothyroxine is unadsorbed. also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 14, 2002
    Publication date: October 16, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030190350
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: October 9, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030191185
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: October 9, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Methods of stabilizing pharmaceutical compositions
    Publication number: 20030190349
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: October 9, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030190359
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: October 9, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Non-granulated levothyroxine pharmaceutical compositions
    Publication number: 20030185885
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: October 2, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030181524
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 25, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030180356
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 25, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Stabilized pharmaceutical compositions
    Publication number: 20030180353
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: August 10, 2002
    Publication date: September 25, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Phillip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030175337
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 18, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030171436
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 11, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma
  • Levothyroxine compositions having unique triiodothyronine Tmax properties
    Publication number: 20030165564
    Abstract: The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
    Type: Application
    Filed: October 29, 2002
    Publication date: September 4, 2003
    Inventors: G. Andrew Franz, Elaine A. Strauss, Philip A. DiMenna, Rocco L. Gemma